Short answer
MESA LABORATORIES INC /CO/ (MLAB) filed its Q3 2026 10-Q quarterly report on Nov 9, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $62M (up 2.6% year over year) with net income of $4M.
Q3 2026 key financials · XBRL
- Revenue
- $62M
- +2.6% YoY · +3.7% QoQ
- Net income
- $4M
- +75.3% YoY · +53.4% QoQ
- Operating margin
- 13.5%
- Gross margin
- 64.0%
- EPS (diluted)
- $0.76
- +68.9% YoY · +55.1% QoQ
Source: XBRL data from the MESA LABORATORIES INC /CO/ (MLAB) Q3 2026 10-Q on SEC EDGAR. USD.
MESA LABORATORIES INC /CO/ Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material risk-factor changes during quarter, per filing
- Carried-forward risks remain those disclosed in March 31, 2026 Form 10-K
- Credit agreement amended September 16, 2026, indicating potential financing-risk developments
- New share repurchase program approved November 4, 2026, after quarter-end, affecting capital-allocation risk
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other MESA LABORATORIES INC /CO/ quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.